GSK

Recent Articles

5 Trump-Proof Pharma Dividend Stocks to Buy

Pharma is under the proverbial gun as Trump takes office, but these pharma dividend payers are stocks to buy for the long term More 

7 Blue-Chip Dividend Stocks That Are Dead Weight Right Now

Most blue-chip dividend stocks have adjusted for the prospect of rising interest rates, but a few more are facing additional problems. More 

4 Reasons Why Pfizer Inc. Stock (PFE) Could be a Great Pick in 2017

Pfizer's shares surpassed that of large-cap pharma industry in 2016. PFE stock rose 0.6% in 2016, and here's why 2017 should be just as good More 

10 Dangerous High-Yield Dividend Stocks to Avoid

These high-yield dividend stocks could surprise investors with dividend cuts and weak performance. Beware these siren yields! More 

16 Pharmaceuticals Stocks to Sell Now

The overall ratings of 16 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

13 Pharmaceuticals Stocks to Sell Now

The ratings of 13 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

The Hidden Upside In The Coming Mexican Crisis (HPQ, GE, GSK)

The US relationship with Mexico will change under a Trump presidency. Here are 3 possible winning stocks to consider for investment More